stoxline Quote Chart Rank Option Currency Glossary
  
DarioHealth Corp. (DRIO)
0.6999  0.05 (7.69%)    02-14 16:00
Open: 0.65
High: 0.6999
Volume: 297,798
  
Pre. Close: 0.6499
Low: 0.6438
Market Cap: 27(M)
Technical analysis
2025-02-14 4:47:31 PM
Short term     
Mid term     
Targets 6-month :  1.24 1-year :  1.61
Resists First :  1.06 Second :  1.37
Pivot price 0.64
Supports First :  0.56 Second :  0.46
MAs MA(5) :  0.64 MA(20) :  0.66
MA(100) :  0.83 MA(250) :  1.12
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  48.4 D(3) :  39
RSI RSI(14): 50.9
52-week High :  2.5 Low :  0.56
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ DRIO ] has closed below upper band by 7.5%. Bollinger Bands are 57.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.7 - 0.7 0.7 - 0.71
Low: 0.64 - 0.64 0.64 - 0.64
Close: 0.69 - 0.7 0.7 - 0.71
Company Description

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Headline News

Sat, 08 Feb 2025
DarioHealth Corp. (DRIO) Expands Health Plan Reach with New Blue Cross Blue Shield Agreement - Yahoo Finance

Thu, 06 Feb 2025
DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base - PR Newswire

Thu, 06 Feb 2025
DarioHealth Expands Digital Health Empire with Landmark BCBS Deal - AI Platform Set to Transform $1.2T Market - StockTitan

Thu, 30 Jan 2025
PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation - Business Wire

Tue, 21 Jan 2025
DarioHealth Secures $25.6M Funding, Extends Cash Runway Through Q3 2024 - StockTitan

Tue, 21 Jan 2025
DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025 - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 38 (M)
Shares Float 28 (M)
Held by Insiders 22.8 (%)
Held by Institutions 31 (%)
Shares Short 3,060 (K)
Shares Short P.Month 2,010 (K)
Stock Financials
EPS -0.94
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.87
Profit Margin -205.7 %
Operating Margin -162.1 %
Return on Assets (ttm) -34.8 %
Return on Equity (ttm) -75 %
Qtrly Rev. Growth 111 %
Gross Profit (p.s.) 0.36
Sales Per Share 0.6
EBITDA (p.s.) -1.4
Qtrly Earnings Growth 0 %
Operating Cash Flow -39 (M)
Levered Free Cash Flow -27 (M)
Stock Valuations
PE Ratio -0.76
PEG Ratio 0
Price to Book value 0.37
Price to Sales 1.16
Price to Cash Flow -0.69
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android